New findings from JAVELIN Bladder 100, IMvigor011, and CREST point to better biomarker-driven selection for bladder cancer maintenance immunotherapy.
July 14, 2026
FDA Approvals
Reconsidering Venetoclax Dosing With Azole Antifungals
Grant Drew, PharmD; Kiwon Park, PharmD, et al.
April 16, 2026
Clinical Trials
North American Enrollment in Clinical Trials
Ming-Hei Tai, PharmD, BCOP
April 15, 2026
Clinical Trials
Patient Navigators as Catalysts in Cancer Clinical Trials
Mandi L. Pratt-Chapman, PhD, MA, HON-OPN-CG
April 9, 2026
Recent Updates
The latest breakthroughs, research highlights, and industry developments in oncology.
View More
FDA Approvals
Updates on recent FDA approvals, label expansions, and regulatory decisions that may affect everyday oncology practice.
View More
FDA Approvals
Reconsidering Venetoclax Dosing With Azole Antifungals
Grant Drew, PharmD; Kiwon Park, PharmD, et al.
April 16, 2026